Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study
Selinexor is an oral, selective nuclear export inhibitor. STORM was a phase 2b, single-arm, open-label, multicenter trial of selinexor with low dose dexamethasone in patients with penta-exposed relapsed/refractory multiple myeloma (RRMM) that met its primary endpoint, with overall response of 26% (9...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
06 September 2021
|
| In: |
BMC cancer
Year: 2021, Jahrgang: 21, Pages: 1-10 |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/s12885-021-08453-9 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12885-021-08453-9 Verlag, lizenzpflichtig, Volltext: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-021-08453-9 
|
| Verfasserangaben: | Gabriel Tremblay, Patrick Daniele, Janis Breeze, Lingling Li, Jatin Shah, Sharon Shacham, Michael Kauffman, Monika Engelhardt, Ajaj Chari, Ajay Nooka, Dan Vogl, Maria Gavriatopoulou, Meletios-Athanasios Dimopoulos, Paul Richardson, Noa Biran, David Siegel, Philip Vlummens, Chantal Doyen, Thierry Facon, Mohamad Mohty, Nathalie Meuleman, Moshe Levy, Luciano Costa, James E. Hoffman, Michel Delforge, David Kaminetzky, Katja Weisel, Marc Raab, David Dingli, Sascha Tuchman, Frenzel Laurent, Ravi Vij, Gary Schiller, Philippe Moreau, Joshua Richter, Martin Schreder, Klaus Podar, Terri Parker, Robert Frank Cornell, Karlin Lionel, Sylvain Choquet and Jagannath Sundar |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1777253519 | ||
| 003 | DE-627 | ||
| 005 | 20250103000422.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211111s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12885-021-08453-9 |2 doi | |
| 035 | |a (DE-627)1777253519 | ||
| 035 | |a (DE-599)KXP1777253519 | ||
| 035 | |a (OCoLC)1341423940 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Tremblay, Gabriel |e VerfasserIn |0 (DE-588)124555901X |0 (DE-627)1777255260 |4 aut | |
| 245 | 1 | 0 | |a Quality of life analyses in patients with multiple myeloma |b results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study |c Gabriel Tremblay, Patrick Daniele, Janis Breeze, Lingling Li, Jatin Shah, Sharon Shacham, Michael Kauffman, Monika Engelhardt, Ajaj Chari, Ajay Nooka, Dan Vogl, Maria Gavriatopoulou, Meletios-Athanasios Dimopoulos, Paul Richardson, Noa Biran, David Siegel, Philip Vlummens, Chantal Doyen, Thierry Facon, Mohamad Mohty, Nathalie Meuleman, Moshe Levy, Luciano Costa, James E. Hoffman, Michel Delforge, David Kaminetzky, Katja Weisel, Marc Raab, David Dingli, Sascha Tuchman, Frenzel Laurent, Ravi Vij, Gary Schiller, Philippe Moreau, Joshua Richter, Martin Schreder, Klaus Podar, Terri Parker, Robert Frank Cornell, Karlin Lionel, Sylvain Choquet and Jagannath Sundar |
| 264 | 1 | |c 06 September 2021 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 11.11.2021 | ||
| 520 | |a Selinexor is an oral, selective nuclear export inhibitor. STORM was a phase 2b, single-arm, open-label, multicenter trial of selinexor with low dose dexamethasone in patients with penta-exposed relapsed/refractory multiple myeloma (RRMM) that met its primary endpoint, with overall response of 26% (95% confidence interval [CI], 19 to 35%). Health-related quality of life (HRQoL) was a secondary endpoint measured using the Functional Assessment of Cancer Therapy - Multiple Myeloma (FACT-MM). This study examines impact of selinexor treatment on HRQoL of patients treated in STORM and reports two approaches to calculate minimal clinically important differences for the FACT-MM. | ||
| 650 | 4 | |a FACT-MM | |
| 650 | 4 | |a Health-related quality of life | |
| 650 | 4 | |a Multiple myeloma | |
| 650 | 4 | |a Patient reported outcomes | |
| 650 | 4 | |a Selinexor | |
| 700 | 1 | |a Daniele, Patrick |e VerfasserIn |4 aut | |
| 700 | 1 | |a Breeze, Janis |e VerfasserIn |4 aut | |
| 700 | 1 | |a Li, Lingling |e VerfasserIn |4 aut | |
| 700 | 1 | |a Shah, Jatin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Shacham, Sharon |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kauffman, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |8 1\p |a Engelhardt, Monika |d 1966- |e VerfasserIn |0 (DE-588)113263538 |0 (DE-627)390016233 |0 (DE-576)169992101 |4 aut | |
| 700 | 1 | |a Chari, Ajaj |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nooka, Ajay |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vogl, Dan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gavriatopoulou, Maria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dimopoulos, Meletios-Athanasios |e VerfasserIn |4 aut | |
| 700 | 1 | |a Richardson, Paul |e VerfasserIn |4 aut | |
| 700 | 1 | |a Biran, Noa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Siegel, David |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vlummens, Philip |e VerfasserIn |4 aut | |
| 700 | 1 | |a Doyen, Chantal |e VerfasserIn |4 aut | |
| 700 | 1 | |a Facon, Thierry |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mohty, Mohamad |e VerfasserIn |4 aut | |
| 700 | 1 | |a Meuleman, Nathalie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Levy, Moshe |e VerfasserIn |4 aut | |
| 700 | 1 | |a Costa, Luciano |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hoffman, James E. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Delforge, Michel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kaminetzky, David |e VerfasserIn |4 aut | |
| 700 | 1 | |a Weisel, Katja |e VerfasserIn |4 aut | |
| 700 | 1 | |a Raab, Marc-Steffen |d 1973- |e VerfasserIn |0 (DE-588)124052460 |0 (DE-627)706520998 |0 (DE-576)293998027 |4 aut | |
| 700 | 1 | |a Dingli, David |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tuchman, Sascha |e VerfasserIn |4 aut | |
| 700 | 1 | |a Laurent, Frenzel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vij, Ravi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schiller, Gary |e VerfasserIn |4 aut | |
| 700 | 1 | |a Moreau, Philippe |e VerfasserIn |4 aut | |
| 700 | 1 | |a Richter, Joshua |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schreder, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Podar, Klaus |e VerfasserIn |4 aut | |
| 700 | 1 | |a Parker, Terri |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cornell, Robert Frank |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lionel, Karlin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Choquet, Sylvain |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sundar, Jagannath |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC cancer |d London : BioMed Central, 2001 |g 21(2021), Artikel-ID 993, Seite 1-10 |h Online-Ressource |w (DE-627)326643710 |w (DE-600)2041352-X |w (DE-576)107014645 |x 1471-2407 |7 nnas |a Quality of life analyses in patients with multiple myeloma results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study |
| 773 | 1 | 8 | |g volume:21 |g year:2021 |g elocationid:993 |g pages:1-10 |g extent:10 |a Quality of life analyses in patients with multiple myeloma results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12885-021-08453-9 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://bmccancer.biomedcentral.com/articles/10.1186/s12885-021-08453-9 |x Verlag |z lizenzpflichtig |3 Volltext |
| 883 | |8 1\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 951 | |a AR | ||
| 992 | |a 20211111 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 124052460 |a Raab, Marc-Steffen |m 124052460:Raab, Marc-Steffen |d 910000 |d 910100 |e 910000PR124052460 |e 910100PR124052460 |k 0/910000/ |k 1/910000/910100/ |p 28 | ||
| 999 | |a KXP-PPN1777253519 |e 4001519038 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Tremblay","display":"Tremblay, Gabriel","given":"Gabriel","role":"aut"},{"role":"aut","given":"Patrick","family":"Daniele","display":"Daniele, Patrick"},{"family":"Breeze","display":"Breeze, Janis","given":"Janis","role":"aut"},{"given":"Lingling","role":"aut","family":"Li","display":"Li, Lingling"},{"display":"Shah, Jatin","family":"Shah","given":"Jatin","role":"aut"},{"role":"aut","given":"Sharon","display":"Shacham, Sharon","family":"Shacham"},{"given":"Michael","role":"aut","display":"Kauffman, Michael","family":"Kauffman"},{"display":"Engelhardt, Monika","family":"Engelhardt","role":"aut","given":"Monika"},{"given":"Ajaj","role":"aut","family":"Chari","display":"Chari, Ajaj"},{"given":"Ajay","role":"aut","display":"Nooka, Ajay","family":"Nooka"},{"role":"aut","given":"Dan","family":"Vogl","display":"Vogl, Dan"},{"role":"aut","given":"Maria","display":"Gavriatopoulou, Maria","family":"Gavriatopoulou"},{"given":"Meletios-Athanasios","role":"aut","family":"Dimopoulos","display":"Dimopoulos, Meletios-Athanasios"},{"role":"aut","given":"Paul","family":"Richardson","display":"Richardson, Paul"},{"display":"Biran, Noa","family":"Biran","given":"Noa","role":"aut"},{"given":"David","role":"aut","display":"Siegel, David","family":"Siegel"},{"family":"Vlummens","display":"Vlummens, Philip","given":"Philip","role":"aut"},{"display":"Doyen, Chantal","family":"Doyen","given":"Chantal","role":"aut"},{"family":"Facon","display":"Facon, Thierry","role":"aut","given":"Thierry"},{"role":"aut","given":"Mohamad","display":"Mohty, Mohamad","family":"Mohty"},{"family":"Meuleman","display":"Meuleman, Nathalie","role":"aut","given":"Nathalie"},{"display":"Levy, Moshe","family":"Levy","role":"aut","given":"Moshe"},{"role":"aut","given":"Luciano","display":"Costa, Luciano","family":"Costa"},{"role":"aut","given":"James E.","display":"Hoffman, James E.","family":"Hoffman"},{"family":"Delforge","display":"Delforge, Michel","given":"Michel","role":"aut"},{"role":"aut","given":"David","display":"Kaminetzky, David","family":"Kaminetzky"},{"display":"Weisel, Katja","family":"Weisel","given":"Katja","role":"aut"},{"role":"aut","given":"Marc-Steffen","family":"Raab","display":"Raab, Marc-Steffen"},{"given":"David","role":"aut","family":"Dingli","display":"Dingli, David"},{"family":"Tuchman","display":"Tuchman, Sascha","role":"aut","given":"Sascha"},{"given":"Frenzel","role":"aut","family":"Laurent","display":"Laurent, Frenzel"},{"display":"Vij, Ravi","family":"Vij","given":"Ravi","role":"aut"},{"given":"Gary","role":"aut","display":"Schiller, Gary","family":"Schiller"},{"display":"Moreau, Philippe","family":"Moreau","given":"Philippe","role":"aut"},{"family":"Richter","display":"Richter, Joshua","given":"Joshua","role":"aut"},{"given":"Martin","role":"aut","family":"Schreder","display":"Schreder, Martin"},{"given":"Klaus","role":"aut","display":"Podar, Klaus","family":"Podar"},{"family":"Parker","display":"Parker, Terri","role":"aut","given":"Terri"},{"given":"Robert Frank","role":"aut","family":"Cornell","display":"Cornell, Robert Frank"},{"role":"aut","given":"Karlin","display":"Lionel, Karlin","family":"Lionel"},{"role":"aut","given":"Sylvain","family":"Choquet","display":"Choquet, Sylvain"},{"given":"Jagannath","role":"aut","family":"Sundar","display":"Sundar, Jagannath"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"06 September 2021"}],"note":["Gesehen am 11.11.2021"],"title":[{"title":"Quality of life analyses in patients with multiple myeloma","title_sort":"Quality of life analyses in patients with multiple myeloma","subtitle":"results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study"}],"id":{"doi":["10.1186/s12885-021-08453-9"],"eki":["1777253519"]},"relHost":[{"part":{"year":"2021","pages":"1-10","volume":"21","text":"21(2021), Artikel-ID 993, Seite 1-10","extent":"10"},"language":["eng"],"id":{"eki":["326643710"],"issn":["1471-2407"],"zdb":["2041352-X"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"326643710","type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Quality of life analyses in patients with multiple myeloma results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b studyBMC cancer","pubHistory":["1.2001 -"],"note":["Gesehen am 22.05.20"],"origin":[{"publisherPlace":"London ; Berlin ; Heidelberg","dateIssuedKey":"2001","publisher":"BioMed Central ; Springer","dateIssuedDisp":"2001-"}],"title":[{"title_sort":"BMC cancer","title":"BMC cancer"}]}],"recId":"1777253519","name":{"displayForm":["Gabriel Tremblay, Patrick Daniele, Janis Breeze, Lingling Li, Jatin Shah, Sharon Shacham, Michael Kauffman, Monika Engelhardt, Ajaj Chari, Ajay Nooka, Dan Vogl, Maria Gavriatopoulou, Meletios-Athanasios Dimopoulos, Paul Richardson, Noa Biran, David Siegel, Philip Vlummens, Chantal Doyen, Thierry Facon, Mohamad Mohty, Nathalie Meuleman, Moshe Levy, Luciano Costa, James E. Hoffman, Michel Delforge, David Kaminetzky, Katja Weisel, Marc Raab, David Dingli, Sascha Tuchman, Frenzel Laurent, Ravi Vij, Gary Schiller, Philippe Moreau, Joshua Richter, Martin Schreder, Klaus Podar, Terri Parker, Robert Frank Cornell, Karlin Lionel, Sylvain Choquet and Jagannath Sundar"]},"physDesc":[{"extent":"10 S."}]} | ||
| SRT | |a TREMBLAYGAQUALITYOFL0620 | ||